Paris, France, July 26, 2024: The International Testing Agency reports that a sample collected from Iraqi judoka Sajjad Ghanim Sehen Sehen has returned an adverse analytical finding for the non-specified prohibited substances Metandienone and Boldenone (classified as S1. anabolic androgenic steroid, according to the prohibited lit of the World Anti-Doping Agency).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee during an out-of-competition anti-doping control on July 23, 2024 in Paris. The result was reported by the WADA-accredited laboratory of Paris on July 25, 2024.
The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules applicable to the Olympic Games Paris 2024. This means that the athlete is prevented from competing, training, coaching or participating in any activity during the Olympic Games Paris 2024.
The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division.
The athlete also has the right to request the analysis of the B-sample.